Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy.
Saved in:
| Title: | Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy. |
|---|---|
| Authors: | Hu, Shuyi1, Wu, Zipeng1, Dai, Yingying2, Shi, Xinhong1, Hu, Qin1, Liu, Caolu2, Yifei Zhu1, Ruofan Yu1, Jingwen Li1, Ying Liu1, Tianyi Liu2, Lin Lu2, Chengyun Yao2, Bo Shen1, Meiqi Shi1, Cheng Chen2,3 njmudoctor@163.com, Xiaohua Wang1 wangxiaohua@jszlyy.com.cn, Guoren Zhou1 zhouguoren888@163.com |
| Source: | Cancer Biology & Medicine. Dec2025, Vol. 22 Issue 12, p1544-1552. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
